E Fund CSI Medical Service ETF (159847) falls 1.15%, with a net inflow of 120 million yuan for 12 consecutive days
NewTimeSpace (newtimespace.com) News, as of 13:56 on June 9, 2026, E Fund Medical ETF (159847) fell 1.15%, with the latest price at 0.34 yuan. (The stocks listed above are only index constituents and do not constitute any specific recommendation.)
In terms of liquidity, E Fund Medical ETF recorded an intraday turnover rate of 1.56% and a trading volume of 22.3953 million yuan. Over a longer time frame, as of June 8, the ETF's average daily trading volume over the past week reached 29.4628 million yuan.
In terms of scale, E Fund Medical ETF saw a significant increase of 96.4785 million yuan in scale over the past three months, with the new scale increase ranking 1/4 among comparable funds. (Data source: Wind)
In terms of shares, the latest share count of E Fund Medical ETF reached 4.193 billion units, hitting a one-year high. (Data source: Wind)
In terms of net capital inflow, E Fund Medical ETF saw consecutive net inflows for 12 days, with the highest single-day net inflow reaching 24.4134 million yuan. It attracted a total of 120 million yuan, with an average daily net inflow of 9.9679 million yuan. (Data source: Wind)
Data shows that leveraged funds are continuously positioning. The net margin financing purchase amount of E Fund Medical ETF on the previous trading day reached 2.2970 million yuan, with the latest margin financing balance standing at 25.9825 million yuan. (Data source: Wind)
From the perspective of return capability, as of June 8, 2026, since its inception, E Fund Medical ETF achieved a highest single-month return of 29.92%, a longest streak of consecutive up months of 5 months, a maximum cumulative gain during that streak of 24.30%, and an average return of 5.66% in up months. As of June 8, 2026, the ETF's annualized excess return over its benchmark for the past three months was 2.49%, ranking 1/4 among comparable funds.
In terms of drawdown, as of June 8, 2026, E Fund Medical ETF recorded a drawdown of 0.04% relative to its benchmark since the beginning of the year, the smallest drawdown among comparable funds.
In terms of fees, E Fund Medical ETF has a management fee rate of 0.15% and a custodian fee rate of 0.05%, the lowest fee rates among comparable funds.
In terms of tracking accuracy, as of June 8, 2026, the three-year tracking error of E Fund Medical ETF was 0.037%, achieving the highest tracking accuracy among comparable funds.
From a valuation perspective, the latest price-to-earnings (PE-TTM) ratio of the CSI Medical Index, which E Fund Medical ETF tracks, is only 25.63 times, standing at the 0.39% percentile over the past year. This means the valuation is lower than over 99.61% of the time in the past year, placing it at a historical low.
E Fund Medical ETF closely tracks the CSI Medical Index. The CSI Medical Index selects the securities of listed companies in the healthcare industry whose businesses involve medical devices, medical services, medical informatization, and other medical themes as index constituents, in order to reflect the overall performance of the securities of listed companies in the medical theme.
NewTimeSpace Disclaimer: All content herein is the original work of NewTimeSpace. Any reproduction, reprinting, or use of this content in any other manner must clearly indicate the source as "NewTimeSpace". NewTimeSpace and its authorized third-party information providers strive to ensure the accuracy and reliability of the data, but do not guarantee the absolute correctness thereof. This content is for reference only and does not constitute any investment advice. All transaction risks shall be borne by the user.
- YUNNAN WATER (06839.HK): Changes in Composition of Compliance and Risk Control Committee
- DATANG RENEW (01798.HK): RMB 2 Billion Super-Short-Term Commercial Paper to Be Repaid on 21 August
- ASIAINFO TECH (01675.HK): Grants 1,000,000 Share Options to Employees at HKD 4.522 Per Share
- STAR SHINE HLDG (01440.HK): Expects H1 Net Profit of at Least RMB 24 Million, Turning Around from Loss
- CHINA CINDA (01359.HK): Regulatory Approval Obtained for Appointment of Vice President